Cargando…
Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis
PURPOSE: Starting in 2019, the Global Initiative for Asthma recommended the use of inhaled corticosteroids (ICS) as part of reliever combination therapy in patients 12 years of age and older, thus dramatically increasing the population exposure to ICS. ICS and intranasal corticosteroids (INS) are co...
Autores principales: | Vinokurtseva, Anastasiya, Fung, Matthew, Ai Li, Erica, Zhang, Richard, Armstrong, James J, Hutnik, Cindy M L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165658/ https://www.ncbi.nlm.nih.gov/pubmed/35669010 http://dx.doi.org/10.2147/OPTH.S358066 |
Ejemplares similares
-
ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts
por: Teplitsky, Jack E., et al.
Publicado: (2023) -
Optical coherence tomography for glaucoma diagnosis: An evidence based meta-analysis
por: Kansal, Vinay, et al.
Publicado: (2018) -
Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
por: Ishii, Mai, et al.
Publicado: (2021) -
Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
por: Harasymowycz, Paul, et al.
Publicado: (2021) -
Comparison of Newly Diagnosed Ocular Hypertension and Open-Angle Glaucoma: Ocular Variables, Risk Factors, and Disease Severity
por: Buys, Yvonne M., et al.
Publicado: (2012)